Controversy and debate on dengue vaccine series-paper 3: final response to review of a licensed dengue vaccine: inappropriate subgroup analyses and selective reporting may cause harm in mass vaccination programs

J Clin Epidemiol. 2018 Mar:95:142. doi: 10.1016/j.jclinepi.2017.12.025. Epub 2018 Jan 3.
No abstract available

Publication types

  • Comment

MeSH terms

  • Dengue Vaccines*
  • Dengue*
  • Humans
  • Mass Vaccination

Substances

  • Dengue Vaccines